Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations.
Xiaosheng DingWeiwei ShiBingxuan HanHanxiao ChenJia LiJuan AnLili ZhouWeiran XuHui ShiXixi ZhengYichun HuaXiao-Yan LiPublished in: Thoracic cancer (2023)
Patients with TTF-1-negative and EGFR-mutant LUAD show a diminished response to EGFR-TKIs.